Esomeprazole Magnesium For Suspension
Product Images NDC 69097-529

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 69097-529). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 01

Chemical structure of esomeprazole magnesium shown as a detailed molecular diagram including magnesium ion and hydration state (2 H2O). The structure visually represents the molecular formula of the active ingredient esomeprazole magnesium in the drug.*

FDA Label Image

Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 02

A line graph depicting the percent of patients maintaining response over a six-month period for Esomeprazole magnesium suspension at 10 mg, 20 mg, and 40 mg doses compared to placebo. The x-axis represents months, and the y-axis shows the percent maintained. Higher doses generally sustain higher percentages over time.*

FDA Label Image

Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 03

A line graph showing percent maintained over a 6-month period for different doses of esomeprazole magnesium (10 mg, 20 mg, 40 mg) and placebo. The y-axis represents percent maintained, and the x-axis represents months. The 40 mg and 20 mg doses maintain close to 100% over time, while 10 mg and placebo show a decline.*

FDA Label Image

Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 04

A line graph depicting the percent of patients symptom-free over a 28-day diary period, comparing Esomeprazole magnesium 40 mg, 20 mg, and placebo groups. The x-axis represents diary days from 0 to 28, and the y-axis shows the percent symptom-free ranging from 0 to 100%. Data shows symptom-free percentage trends over time for each treatment.*

FDA Label Image

Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 05

A line graph showing the percentage of patients symptom-free over 28 diary days, comparing Esomeprazole magnesium 40 mg, 20 mg, and placebo groups. The y-axis represents percent symptom-free patients, while the x-axis measures diary days from 0 to 28. Three lines depict outcomes for the 40 mg dose, 20 mg dose, and placebo.*

FDA Label Image

Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 06

Packaging label for Esomeprazole Magnesium Delayed-Release Oral Suspension, 20 mg, by Cipla USA Inc. The label specifies it is a prescription-only human drug for suspension use. Instructions mention the contents are for delayed-release oral suspension and include directions for use. The label also includes the NDC number 69097-528-34, storage conditions, and manufacturer details.*

FDA Label Image

Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 07

Packaging label for Esomeprazole Magnesium 20 mg for Delayed-Release Oral Suspension by Cipla USA Inc. The carton contains 30 child-resistant single dose packets. The label includes storage instructions, directions for pharmacist to dispense a medication guide, and manufacturer details from Cipla Ltd., India. The label shows the NDC 69097-528-34 and includes a barcode and Rx only designation.*

FDA Label Image

Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 08

Label for Esomeprazole Magnesium Delayed-Release Oral Suspension, 40 mg strength, by Cipla USA Inc. The label includes NDC 69097-5293-4 and instructions for use, storage conditions, and manufacturer information. It specifies the dosage form as oral suspension and highlights that the package contains esomeprazole magnesium delayed-release granules for suspension.*

FDA Label Image

Ae7830d2 D0e7 492e 95bb Ad54e8ed3ea6 09

Esomeprazole Magnesium 40 mg for Delayed-Release Oral Suspension carton label by Cipla USA Inc. The packaging states it contains 30 child-resistant single dose packets, with each packet containing Esomeprazole Magnesium Dihydrate USP equivalent to 40 mg of esomeprazole. The label includes directions for preparation and dispensing instructions for pharmacists. The design features a white background with black text and purple highlights for the strength and dosage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.